支气管扩张症、哮喘和慢性阻塞性肺疾病的医疗费用及资源利用情况。
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD.
作者信息
Ronco Raffaella, Franco Giovanni, Monzio Compagnoni Matteo, Aliberti Stefano, Luppi Fabrizio, Corrao Giovani, Faverio Paola
机构信息
National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
Laboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
出版信息
ERJ Open Res. 2023 Jul 31;9(4). doi: 10.1183/23120541.00158-2023. eCollection 2023 Jul.
相似文献
1
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD.支气管扩张症、哮喘和慢性阻塞性肺疾病的医疗费用及资源利用情况。
ERJ Open Res. 2023 Jul 31;9(4). doi: 10.1183/23120541.00158-2023. eCollection 2023 Jul.
2
Incidence and Healthcare Burden of Pertussis among Older Adults with and without Pre-Existing Chronic Obstructive Pulmonary Disease or Asthma in South Korea.韩国患有和未患有慢性阻塞性肺疾病或哮喘的老年人百日咳的发病率和医疗负担
COPD. 2023 Dec;20(1):126-134. doi: 10.1080/15412555.2023.2169120.
3
Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).慢性阻塞性肺疾病（COPD）患者接受噻托溴铵加常规护理与仅接受常规护理治疗1年后的医疗费用。
Pharmacoeconomics. 2004;22(11):741-9. doi: 10.2165/00019053-200422110-00004.
4
Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study.探索澳大利亚北部顶端地区的澳大利亚原住民使用吸入性药物治疗的处方实践是否合适：一项回顾性队列研究。
BMJ Open Respir Res. 2023 Mar;10(1). doi: 10.1136/bmjresp-2022-001508.
5
Clinical Outcomes of Noninvasive Ventilation in Asthma, Bronchiectasis, and Other COPD.哮喘、支气管扩张症和其他 COPD 患者的无创通气临床结局。
South Med J. 2021 Dec;114(12):766-771. doi: 10.14423/SMJ.0000000000001329.
6
The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis.α-1 抗胰蛋白酶基因型在 COPD/肺气肿、哮喘和支气管扩张症患者中的分布。
Int J Chron Obstruct Pulmon Dis. 2020 Nov 6;15:2827-2836. doi: 10.2147/COPD.S271810. eCollection 2020.
7
Evolution and Comparative Analysis of Hospitalizations in Spain Due to COPD and Bronchiectasis between 2004 and 2015.2004 年至 2015 年期间西班牙因 COPD 和支气管扩张症住院的演变和比较分析。
COPD. 2021 Apr;18(2):210-218. doi: 10.1080/15412555.2021.1896692. Epub 2021 Mar 17.
8
Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort.德国 COPD 家庭远程监测的健康经济评价：来自大型基于人群队列的证据。
Eur J Health Econ. 2017 Sep;18(7):869-882. doi: 10.1007/s10198-016-0834-x. Epub 2016 Oct 3.
9
Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study.在轻度至中度哮喘合并过敏性鼻炎患者中，在当前治疗方案中添加孟鲁司特的医疗保健利用情况及成本：PRAACTICAL研究
Pharmacoeconomics. 2007;25(8):665-76. doi: 10.2165/00019053-200725080-00004.
10
Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD.体力活动与严重哮喘、支气管扩张和 COPD 的疾病特征有关。
Respirology. 2019 Apr;24(4):352-360. doi: 10.1111/resp.13428. Epub 2018 Nov 1.
引用本文的文献
1
Cough in non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症中的咳嗽
ERJ Open Res. 2024 Dec 2;10(6). doi: 10.1183/23120541.00330-2024. eCollection 2024 Nov.
2
Epidemiology of bronchiectasis.支气管扩张症的流行病学。
Eur Respir Rev. 2024 Oct 9;33(174). doi: 10.1183/16000617.0091-2024. Print 2024 Oct.
本文引用的文献
1
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study.度匹鲁单抗治疗哮喘的疗效和经济影响：基于人群的队列研究。
Respir Res. 2023 Mar 7;24(1):70. doi: 10.1186/s12931-023-02372-y.
2
Increased hospitalizations and economic burden in COPD with bronchiectasis: a nationwide representative study.支气管扩张症合并 COPD 患者的住院率和经济负担增加：一项全国代表性研究。
Sci Rep. 2022 Mar 9;12(1):3829. doi: 10.1038/s41598-022-07772-6.
3
Bronchiectasis: moving from an orphan disease to an unpleasant socioeconomic burden.支气管扩张症：从一种罕见病转变为令人不快的社会经济负担。
ERJ Open Res. 2021 Oct 25;7(4). doi: 10.1183/23120541.00507-2021. eCollection 2021 Oct.
4
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations.支气管扩张症在成人中的放射学和临床诊断标准及定义：用于临床试验的国际共识建议。
Lancet Respir Med. 2022 Mar;10(3):298-306. doi: 10.1016/S2213-2600(21)00277-0. Epub 2021 Sep 24.
5
Prevalence and incidence of bronchiectasis in Italy.意大利支气管扩张症的患病率和发病率。
BMC Pulm Med. 2020 Jan 16;20(1):15. doi: 10.1186/s12890-020-1050-0.
6
The significant global economic burden of bronchiectasis: a pending matter.支气管扩张症的重大全球经济负担：一个悬而未决的问题。
Eur Respir J. 2019 Feb 28;53(2). doi: 10.1183/13993003.02392-2018. Print 2019 Feb.
7
The economic burden of bronchiectasis - known and unknown: a systematic review.支气管扩张症的经济负担——已知和未知：系统评价。
BMC Pulm Med. 2019 Feb 28;19(1):54. doi: 10.1186/s12890-019-0818-6.
8
Economic burden of bronchiectasis in Germany.支气管扩张症在德国的经济负担。
Eur Respir J. 2019 Feb 28;53(2). doi: 10.1183/13993003.02033-2018. Print 2019 Feb.
9
Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy.利用行政数据开发并验证一种新型多源合并症评分：一项来自意大利的大型基于人群的队列研究。
BMJ Open. 2017 Dec 26;7(12):e019503. doi: 10.1136/bmjopen-2017-019503.
10
Time Trends in Hospital Admissions for Bronchiectasis: Analysis of the Spanish National Hospital Discharge Data (2004 to 2013).支气管扩张症住院情况的时间趋势：对西班牙国家医院出院数据（2004年至2013年）的分析
PLoS One. 2016 Sep 13;11(9):e0162282. doi: 10.1371/journal.pone.0162282. eCollection 2016.
Zotero 插件